The programme is a top-tier digital health accelerator with a 4% acceptance rate, which aligns with the venture's healthtech focus. However, the venture is pre-revenue and pre-incorporation, which may be too early for this competitive cohort, and the programme's deadline is already past (2026 cohort announced).